AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomerâ„¢ RNA editing program to enter the clinic Company to host virtual ...
Chardan analyst Keay Nakae raised the firm’s price target on ProQR Therapeutics (PRQR) to $4 from $2.50 and keeps a Buy rating on the ...
We'll unveil the top 10 clothing brand logos that have conquered the fashion industry and left an indelible mark on our collective consciousness. If there's one thing that can instantly grab our ...